• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].[治疗后非小细胞肺癌骨转移的危险因素]
Zhongguo Fei Ai Za Zhi. 2018 Jun 20;21(6):476-480. doi: 10.3779/j.issn.1009-3419.2018.06.09.
2
[Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].[非小细胞肺癌患者凝血异常及预后相关因素分析]
Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):789-96. doi: 10.3779/j.issn.1009-3419.2014.11.04.
3
Plasma D-Dimer Level Correlates with Age, Metastasis, Recurrence, Tumor-Node-Metastasis Classification (TNM), and Treatment of Non-Small-Cell Lung Cancer (NSCLC) Patients.血浆 D-二聚体水平与非小细胞肺癌(NSCLC)患者的年龄、转移、复发、肿瘤-淋巴结-转移(TNM)分类和治疗相关。
Biomed Res Int. 2021 Oct 19;2021:9623571. doi: 10.1155/2021/9623571. eCollection 2021.
4
Prevalence of bone pain decreases as lymph node stage increases in nonsmall cell lung cancer patients.非小细胞肺癌患者的淋巴结分期越高,骨痛的发生率越低。
Curr Probl Cancer. 2019 Feb;43(1):86-91. doi: 10.1016/j.currproblcancer.2018.08.006. Epub 2018 Sep 4.
5
Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.非小细胞肺癌骨转移患者发生骨相关事件(SREs)的危险因素及影响无SRE生存的因素。
Tumour Biol. 2016 Jan;37(1):1131-40. doi: 10.1007/s13277-015-3907-z. Epub 2015 Aug 15.
6
Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.非小细胞肺癌脑转移的风险因素:一项观察性研究方案。
Medicine (Baltimore). 2021 Mar 5;100(9):e24724. doi: 10.1097/MD.0000000000024724.
7
[Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].[TNM分期及治疗方式对非小细胞肺癌预后的影响]
Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):465-8.
8
Risk factors for bone metastasis in completely resected non-small-cell lung cancer.完全切除的非小细胞肺癌骨转移的危险因素。
Future Oncol. 2017 Apr;13(8):695-704. doi: 10.2217/fon-2016-0237. Epub 2016 Nov 21.
9
Risk factor analysis of bone metastasis in patients with non-small cell lung cancer.非小细胞肺癌患者骨转移的危险因素分析
Am J Transl Res. 2022 Sep 15;14(9):6696-6702. eCollection 2022.
10
Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer.非小细胞肺癌骨转移患者的临床特征和预后因素。
J Int Med Res. 2020 May;48(5):300060520925644. doi: 10.1177/0300060520925644.

引用本文的文献

1
Clinical association between coagulation indicators and bone metastasis in patients with gastric cancer.胃癌患者凝血指标与骨转移之间的临床关联
World J Gastrointest Oncol. 2023 Jul 15;15(7):1253-1261. doi: 10.4251/wjgo.v15.i7.1253.
2
Identification of the potential ferroptosis key genes in lung cancer with bone metastasis.伴有骨转移的肺癌中潜在铁死亡关键基因的鉴定
J Thorac Dis. 2023 May 30;15(5):2708-2720. doi: 10.21037/jtd-23-539. Epub 2023 May 29.

本文引用的文献

1
Impact of metastatic status on the prognosis of mutation-positive non-small cell lung cancer patients treated with first-generation EGFR-tyrosine kinase inhibitors.转移状态对接受第一代表皮生长因子受体酪氨酸激酶抑制剂治疗的突变阳性非小细胞肺癌患者预后的影响。
Oncol Lett. 2017 Dec;14(6):7589-7596. doi: 10.3892/ol.2017.7125. Epub 2017 Oct 3.
2
Prognostic score for life expectancy evaluation of lung cancer patients after bone metastasis.用于评估肺癌骨转移患者预期寿命的预后评分
J Bone Oncol. 2017 Nov 3;10:1-5. doi: 10.1016/j.jbo.2017.10.001. eCollection 2018 Mar.
3
Prognostic significance of sites of extrathoracic metastasis in patients with non-small cell lung cancer.非小细胞肺癌患者胸外转移部位的预后意义
J Thorac Dis. 2017 Jul;9(7):1903-1910. doi: 10.21037/jtd.2017.06.117.
4
Risk factors for bone metastasis in completely resected non-small-cell lung cancer.完全切除的非小细胞肺癌骨转移的危险因素。
Future Oncol. 2017 Apr;13(8):695-704. doi: 10.2217/fon-2016-0237. Epub 2016 Nov 21.
5
Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery.特定的KRAS氨基酸取代和EGFR突变可预测非小细胞肺癌手术后的部位特异性复发和转移。
Br J Cancer. 2016 Jul 26;115(3):346-53. doi: 10.1038/bjc.2016.182. Epub 2016 Jun 23.
6
The relationship between lung cancer histology and the clinicopathological characteristics of bone metastases.肺癌组织学与骨转移瘤临床病理特征之间的关系
Lung Cancer. 2016 Jun;96:19-24. doi: 10.1016/j.lungcan.2016.03.014. Epub 2016 Mar 26.
7
Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancer.非小细胞肺癌根治性放疗后首次转移部位的预后及预测因素
Acta Oncol. 2016 Aug;55(8):1022-8. doi: 10.3109/0284186X.2016.1154602. Epub 2016 Apr 8.
8
Progression and metastasis of lung cancer.肺癌的进展与转移
Cancer Metastasis Rev. 2016 Mar;35(1):75-91. doi: 10.1007/s10555-016-9618-0.
9
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
10
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.非小细胞肺癌骨转移的自然病史
Sci Rep. 2015 Dec 22;5:18670. doi: 10.1038/srep18670.

[治疗后非小细胞肺癌骨转移的危险因素]

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

作者信息

Yao Yuanshan, Zhou Yinjie, Yang Zhenhua, Shen Haibo

机构信息

Department of Thoracic Surgery, Ningbo No.2 Hospital, Ningbo 315010, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2018 Jun 20;21(6):476-480. doi: 10.3779/j.issn.1009-3419.2018.06.09.

DOI:10.3779/j.issn.1009-3419.2018.06.09
PMID:29945707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6022027/
Abstract

BACKGROUND

Lung cancer is the leading cause of cancer-related deaths, patients with non-small cell lung cancer (NSCLC) usually have distant metastases, such as bone metastasis, brain metastasis, and lung metastasis. The purpose of this study was to explore the risk factors for bone metastasis in NSCLC patients.

METHODS

A total of 176 cases of NSCLC were selected from May 2009 to May 2011, and patients were divided into two groups, namely the bone metastasis group and non-bone metastasis group. The general clinicopathological data of the two groups and analyzing the independent risk factors of bone metastasis were compared.

RESULTS

In the general clinicopathological data of NSCLC patients. The thrombus or not and tumor-node-metastasis (TNM) stage were closely related to the occurrence of bone metastasis, and were statistically significant (all P<0.01). Prothrombin time, activated partial thromboplastin time, Fibrinogen, thrombin time, blood platelet, D-Dimer and alkaline phosphatase have significantly difference between the two groups (all P<0.05). Logistic regression analysis showed that fibrinogen, activated partial thromboplast in time, alkaline phosphatase, T4 phase, N3 phase and d-dimer were independent risk factors for bone metastasis in NSCLC patients.

CONCLUSIONS: Fibrinogen, alkaline phosphatase, T3, N2 stage and D-Dimer is the independent risk factors of bone metastases in patients with NSCLC.
.

摘要

背景

肺癌是癌症相关死亡的主要原因,非小细胞肺癌(NSCLC)患者通常会发生远处转移,如骨转移、脑转移和肺转移。本研究旨在探讨NSCLC患者骨转移的危险因素。

方法

选取2009年5月至2011年5月期间的176例NSCLC患者,将患者分为两组,即骨转移组和非骨转移组。比较两组的一般临床病理资料并分析骨转移的独立危险因素。

结果

在NSCLC患者的一般临床病理资料中。是否存在血栓以及肿瘤-淋巴结-转移(TNM)分期与骨转移的发生密切相关,且具有统计学意义(均P<0.01)。两组患者的凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原、凝血酶时间、血小板、D-二聚体和碱性磷酸酶有显著差异(均P<0.05)。Logistic回归分析显示,纤维蛋白原、活化部分凝血活酶时间、碱性磷酸酶、T4期、N3期和D-二聚体是NSCLC患者骨转移的独立危险因素。

结论

纤维蛋白原、碱性磷酸酶、T3、N2期和D-二聚体是NSCLC患者骨转移的独立危险因素。